VOLV.A

307.8

-1.28%↓

ASSA.B

343.5

+0.03%↑

SEB.A

175.85

-0.28%↓

SAAB.B

641

-1.16%↓

SKA.B

238.2

-0.83%↓

VOLV.A

307.8

-1.28%↓

ASSA.B

343.5

+0.03%↑

SEB.A

175.85

-0.28%↓

SAAB.B

641

-1.16%↓

SKA.B

238.2

-0.83%↓

VOLV.A

307.8

-1.28%↓

ASSA.B

343.5

+0.03%↑

SEB.A

175.85

-0.28%↓

SAAB.B

641

-1.16%↓

SKA.B

238.2

-0.83%↓

VOLV.A

307.8

-1.28%↓

ASSA.B

343.5

+0.03%↑

SEB.A

175.85

-0.28%↓

SAAB.B

641

-1.16%↓

SKA.B

238.2

-0.83%↓

VOLV.A

307.8

-1.28%↓

ASSA.B

343.5

+0.03%↑

SEB.A

175.85

-0.28%↓

SAAB.B

641

-1.16%↓

SKA.B

238.2

-0.83%↓

Kodu・Aktsiate loetelu・LIFCO AB-B SHS

LIFCO AB-B SHS

Suletud

276.8 -3.15

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

276.8

Max

278.2

Põhinäitajad
By Trading Economics
Sissetulek	524M 1.4B
Müük	692M 7.5B
P/E Sektori keskmine	34.7 51.05
Aktsiakasum	2.29
Dividenditootlus	0.96
Kasumimarginaal	18.795
Töötajad	7,814
EBITDA	211M 1.9B

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	0.96% 2.30%
Järgmine tulemuste avaldamine	28. apr 2026

Turustatistika
By TradingEconomics
Turukapital	-18B 126B
Eelmine avamishind	279.95
Eelmine sulgemishind	276.8

LIFCO AB-B SHS Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. apr 2026, 23:17 UTC

Tulu

Samsung Forecasts Record First-Quarter Operating Profit

6. apr 2026, 23:00 UTC

Kuumad aktsiad

Stocks to Watch: Health Insurers, Mawson, Owlet

6. apr 2026, 22:13 UTC

Suurimad hinnamuutused turgudel

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6. apr 2026, 21:46 UTC

Omandamised, ülevõtmised, äriostud

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6. apr 2026, 17:09 UTC

Suurimad hinnamuutused turgudel

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6. apr 2026, 16:56 UTC

Uudisväärsed sündmused

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6. apr 2026, 14:47 UTC

Suurimad hinnamuutused turgudel

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7. apr 2026, 00:00 UTC

Uudisväärsed sündmused

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6. apr 2026, 23:58 UTC

Market Talk

Uudisväärsed sündmused

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6. apr 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6. apr 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6. apr 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6. apr 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6. apr 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6. apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6. apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6. apr 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6. apr 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6. apr 2026, 18:36 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 17:59 UTC

Market Talk

Uudisväärsed sündmused

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6. apr 2026, 17:13 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6. apr 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. apr 2026, 14:59 UTC

Tulu

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Võrdlus sarnastega

Hinnamuutus

LIFCO AB-B SHS Prognoos

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest LIFCO AB-B SHS

Lifco AB (publ) engages in the dental, demolition and tools, and systems solutions businesses in Sweden, Norway, Germany, rest of Europe, the United Kingdom, Asia, Australia, Italy, North America, and internationally. It is involved in the distribution of dental equipment, such as denture attachments, disinfectants, saliva ejectors, bite registration and dental impression materials, bonding agents, and other consumables, as well as develops and sells medical record systems. The company also operates dental laboratory. In addition, it develops, manufactures, and sells demolition robots, forest machines, and crane and excavator attachments to heavy machine manufacturing, infrastructure, demolition, construction, forestry, nuclear, cement, and process industries. Further, the company offers machinery and equipment for electrical installations and electricity production, electrical equipment, equipment for recycling of various materials, compressors for ships and offshore installations, interiors for service vehicles, and trailers for vehicle transports. The company was founded in 1993 and is based in Enköping, Sweden. Lifco AB (publ) is a subsidiary of Carl Bennet AB.